aod9604 lipolysis AOD-9604 5mg — Fat-Metabolism + Support – PEPTIVE PEPT AOD-9604 (10mg) - NOX Peptides

(2000), Horm Res 53(Suppl 3), PubMed 10971106 Statistics from preclinical literature AOD-9604 = modified fragment of hGH 177191 + N-terminal Tyr (sequence Tyr-Leu-Arg-Ile-Val-Gln-Cys-Arg-Ser-Val-Glu-Gly-Ser-Cys-Gly-Phe), molecular weight 1815.1 Da Developed at Metabolic Pharmaceuticals (Australia) based on the work of professor Frank Ng (Monash University) in the 1990s Standard experimental dose in obesity clinical trials: 1 mg/day subcutaneously (Phase 2b, Heffernan et al.) Mechanism: stimulation of 3-adrenergic receptors in adipose tissue, increased lipolysis and fatty acid oxidation without activation of the hGH receptor (no IGF-1 increase) Phase 2b clinical trial (2007, 300 patients): weight reduction ~2.8 kg vs placebo over 12 weeks FDA status: NDI rejection (2014) as a dietary supplement

We can help guide you to the appropriate medical professionals for further testing and diagnosis if we suspect a Vitamin B12 deficiency during a routine skin examination

E53.0 - Riboflavin deficiency: Vitamin B2 (Riboflavin) deficiency can lead to a deficiency of other B vitamins, including Vitamin B12

Vitamin B12 for Injection (Shot) Cyanocobalamin 1,000mcg by Somerset Therapeutics used to treat low levels (deficiency) of this vitamin